Biolojic Design, Ltd. logo

Biolojic Design, Ltd.

Biolojic Design is a biopharmaceutical company dedicated to the development of human antibody-based therapeutics for cancer and other diseases

74 employees · est. 2009 · Rehovot, Israel

VS
Yumab GmbH logo

Yumab GmbH

From Target to Lead

20 employees · est. 2012 · Braunschweig, Germany

Biolojic Design, Ltd. is the older company (2009 vs 2012); Biolojic Design, Ltd. is the larger of the two.

Side-by-Side Comparison

Biolojic Design, Ltd. Yumab GmbH
Founded
2009 older 2012
Headquarters
Rehovot, Israel Braunschweig, Germany
Employees
74 larger 20
Industry
AI, Biotechnology, Pharmaceutical Biotechnology, Health and Wellness
Funding Stage
Unknown Not tracked yet
Total Funding
$3.95M Not tracked yet
Funding Rounds
2 Not tracked yet
Services
Engineering epitope-specific and multibodies, Developing programmable antibodies, Leveraging AI and machine learning in drug design Not tracked yet
Target Customers
Pharmaceutical Companies, Biotechnology Researchers, Healthcare Providers Not tracked yet
Taxonomy
Biopharmaceutical, Antibody-based Therapeutics, Cancer Treatment, AI-powered Drug Design, Human Antibodies, Antibody Engineering, Functional Epitopes, MAbs, Multibodies, Multi-specific Antibodies, Biological Targets, Complex Diseases, Therapeutic Development Biotech Company, Monoclonal Antibodies, Antibody Engineering, Humanization, Antibody Libraries, Antibody Discovery, Therapeutic Antibodies, Contract Research, R&D Services, Immunotherapy, Phage Display, Antibody Optimization, Antibody Affinity Maturation, Antibody Formats
Website
biolojic.com yumab.com
Biolojic Design, Ltd. logo

About Biolojic Design, Ltd.

Biolojic Design, Ltd. is a pioneering biopharmaceutical company focused on developing innovative human antibody-based therapeutics aimed at treating cancer and other diseases. Founded in 2009, this Israeli startup leverages cutting-edge biotechnology and AI to target functional epitopes, addressing...

Yumab GmbH logo

About Yumab GmbH

Yumab GmbH is a German biotech company founded in 2012 as a spin-off from the University of Braunschweig. The company has made significant strides in human monoclonal antibody (mAb) development, aligning with the prevailing trend in immunotherapy towards fully human mAbs for therapeutic applications...

We will tell you when either one moves

BounceWatch watches Biolojic Design, Ltd. and Yumab GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Biolojic Design, Ltd. and Yumab GmbH — by email.

Frequently Asked Questions

Biolojic Design, Ltd. — Biolojic Design is a biopharmaceutical company dedicated to the development of human antibody-based therapeutics for cancer and other diseases. Yumab GmbH — From Target to Lead. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Biolojic Design, Ltd. has raised $3.95M while Yumab GmbH has raised undisclosed funding.
Biolojic Design, Ltd. and Yumab GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Biolojic Design, Ltd. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Biolojic Design, Ltd. on 15 Jun 2026, and Yumab GmbH on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes